Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Large molecules, production Model

The titanosilicate version of UTD-1 has been shown to be an effective catalyst for the oxidation of alkanes, alkenes, and alcohols (77-79) by using peroxides as the oxidant. The large pores of Ti-UTD-1 readily accommodate large molecules such as 2,6-di-ferf-butylphenol (2,6-DTBP). The bulky 2,6-DTBP substrate can be converted to the corresponding quinone with activity and selectivity comparable to the mesoporous catalysts Ti-MCM-41 and Ti-HMS (80), where HMS = hexagonal mesoporous silica. Both Ti-UTD-1 and UTD-1 have also been prepared as oriented thin films via a laser ablation technique (81-85). Continuous UTD-1 membranes with the channels oriented normal to the substrate surface have been employed in a catalytic oxidation-separation process (82). At room temperature, a cyclohexene-ferf-butylhydroperoxide was passed through the membrane and epoxidation products were trapped on the down stream side. The UTD-1 membranes supported on metal frits have also been evaluated for the separation of linear paraffins and aromatics (83). In a model separation of n-hexane and toluene, enhanced permeation of the linear alkane was observed. Oriented UTD-1 films have also been evenly coated on small 3D objects such as glass and metal beads (84, 85). [Pg.234]

Fig. 1 Inhaled drug in a carrier can exist in the slow clearing pulmonary compartment (Pi) without mucociliary clearance or in the faster clearing pulmonary compartment with mucociliary clearance (P2), tracheobronchial compartment (TB) or gastrointestinal tract (GI). When the drug is released into these compartment (the released drug is represented by italicized letters Pi, P2, TB, GI), it can be absorbed into the bloodstream, or it can be removed by non-productive pathways such as mucociliary clearance represented by the vertical arrows, or chemical and enzymatic decomposition. Large molecules may also enter lymphatics before they appear in the blood stream. (The detailed model was described while the simplified three-compartment model represented by the ellipses is from Refl l)... Fig. 1 Inhaled drug in a carrier can exist in the slow clearing pulmonary compartment (Pi) without mucociliary clearance or in the faster clearing pulmonary compartment with mucociliary clearance (P2), tracheobronchial compartment (TB) or gastrointestinal tract (GI). When the drug is released into these compartment (the released drug is represented by italicized letters Pi, P2, TB, GI), it can be absorbed into the bloodstream, or it can be removed by non-productive pathways such as mucociliary clearance represented by the vertical arrows, or chemical and enzymatic decomposition. Large molecules may also enter lymphatics before they appear in the blood stream. (The detailed model was described while the simplified three-compartment model represented by the ellipses is from Refl l)...
Many products are large molecules, so that they are solids under normal conditions. Solids formation is still less well understood than processes involving fluids and there is a lack of reliable models. Furthermore, experimental physico-chemical data that underpin almost all chemical engineering calculations are rarely available. Good, validated estimation methods are needed. [Pg.57]

Although the steady-state models can most likely account for many of the observed features of diffuse clouds, additional shocked layers appear necessary to reproduce the measured abundances and part of the H2 rotational excitation. It is still not known how ubiquitous shocks are in diffuse clouds, and to what extent they contribute to the formation of other molecules. It would be of interest to find a diffuse cloud which does not show any shock signatures, but still has substantial molecular abundances. Grain surface production of molecules other than H2 in the classical diffuse clouds is evidently very inefficient, although large molecules or small grains may play a role in the ionization balance. [Pg.235]


See other pages where Large molecules, production Model is mentioned: [Pg.27]    [Pg.29]    [Pg.30]    [Pg.26]    [Pg.190]    [Pg.195]    [Pg.276]    [Pg.26]    [Pg.551]    [Pg.719]    [Pg.290]    [Pg.147]    [Pg.282]    [Pg.704]    [Pg.33]    [Pg.118]    [Pg.836]    [Pg.406]    [Pg.13]    [Pg.287]    [Pg.482]    [Pg.282]    [Pg.1092]    [Pg.445]    [Pg.394]    [Pg.324]    [Pg.302]    [Pg.67]    [Pg.132]    [Pg.36]    [Pg.1]    [Pg.17]    [Pg.142]    [Pg.575]    [Pg.147]    [Pg.69]    [Pg.10]    [Pg.189]    [Pg.215]    [Pg.2448]    [Pg.5]    [Pg.130]    [Pg.238]    [Pg.375]    [Pg.373]    [Pg.510]   
See also in sourсe #XX -- [ Pg.4 , Pg.35 ]




SEARCH



Large molecules, production

Large production

Model product

Molecules large

Molecules modeling

Product molecules

Production models

© 2024 chempedia.info